SK53597A3 - A storage stable water solution for infusion containing a thrombin inhibitor - Google Patents

A storage stable water solution for infusion containing a thrombin inhibitor Download PDF

Info

Publication number
SK53597A3
SK53597A3 SK535-97A SK53597A SK53597A3 SK 53597 A3 SK53597 A3 SK 53597A3 SK 53597 A SK53597 A SK 53597A SK 53597 A3 SK53597 A3 SK 53597A3
Authority
SK
Slovakia
Prior art keywords
solution
nag
pic
cha
hooc
Prior art date
Application number
SK535-97A
Other languages
English (en)
Slovak (sk)
Inventor
Ulla Stjernfelt
Mats Sundgren
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of SK53597A3 publication Critical patent/SK53597A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SK535-97A 1994-11-08 1995-10-19 A storage stable water solution for infusion containing a thrombin inhibitor SK53597A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9403831A SE504185C2 (sv) 1994-11-08 1994-11-08 Lagringsstabil vattenlösning för infusion av trombininhibitorer
PCT/SE1995/001228 WO1996014084A1 (fr) 1994-11-08 1995-10-19 Solution aqueuse stable au stockage destinee a l'injection, qui contient un inhibiteur de thrombine

Publications (1)

Publication Number Publication Date
SK53597A3 true SK53597A3 (en) 1998-07-08

Family

ID=20395892

Family Applications (1)

Application Number Title Priority Date Filing Date
SK535-97A SK53597A3 (en) 1994-11-08 1995-10-19 A storage stable water solution for infusion containing a thrombin inhibitor

Country Status (31)

Country Link
US (1) US5830865A (fr)
EP (1) EP0789585B1 (fr)
JP (1) JPH10508598A (fr)
KR (1) KR100416677B1 (fr)
CN (1) CN1090508C (fr)
AT (1) ATE205399T1 (fr)
AU (1) AU695719B2 (fr)
BR (1) BR9509634A (fr)
CA (1) CA2203396A1 (fr)
CZ (1) CZ287256B6 (fr)
DE (1) DE69522702T2 (fr)
DK (1) DK0789585T3 (fr)
EE (1) EE9700218A (fr)
ES (1) ES2163528T3 (fr)
FI (1) FI971949A0 (fr)
HU (1) HU217073B (fr)
IL (1) IL115879A (fr)
IS (1) IS4468A (fr)
MX (1) MX9703339A (fr)
MY (1) MY112593A (fr)
NO (1) NO322048B1 (fr)
NZ (1) NZ295492A (fr)
PL (1) PL320342A1 (fr)
PT (1) PT789585E (fr)
RU (1) RU2164803C2 (fr)
SE (1) SE504185C2 (fr)
SK (1) SK53597A3 (fr)
TR (1) TR199501391A2 (fr)
TW (1) TW407057B (fr)
WO (1) WO1996014084A1 (fr)
ZA (1) ZA959377B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
US6984627B1 (en) * 1993-06-03 2006-01-10 Astrazeneca Ab Peptide derivatives
TWI238827B (en) * 1995-12-21 2005-09-01 Astrazeneca Ab Prodrugs of thrombin inhibitors
SE9802974D0 (sv) * 1998-09-03 1998-09-03 Astra Ab New crystalline forms
US6462021B1 (en) 2000-11-06 2002-10-08 Astrazeneca Ab Use of low molecular weight thrombin inhibitor
DK1569912T3 (en) 2002-12-03 2015-06-29 Pharmacyclics Inc 2- (2-hydroxybiphenyl-3-yl) -1h-benzoimidazole-5-carboxamidine derivatives as factor VIIa inhibitors.
US7345093B2 (en) * 2004-04-27 2008-03-18 Formatech, Inc. Methods of enhancing solubility of compounds
US10143652B2 (en) 2009-09-23 2018-12-04 Curirx Inc. Methods for the preparation of liposomes
WO2011038068A1 (fr) * 2009-09-23 2011-03-31 Formatech, Inc. Méthodes de préparation de liposomes
US20110070294A1 (en) * 2009-09-23 2011-03-24 Javeri Indu Methods for the Administration of Drugs Using Liposomes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9103612D0 (sv) * 1991-12-04 1991-12-04 Astra Ab New peptide derivatives
US5466131A (en) * 1994-03-22 1995-11-14 Micropump Corporation Multiple-chamber gear pump with hydraulically connected chambers

Also Published As

Publication number Publication date
FI971949A (fi) 1997-05-07
PL320342A1 (en) 1997-09-29
US5830865A (en) 1998-11-03
EP0789585A1 (fr) 1997-08-20
HU217073B (hu) 1999-11-29
FI971949A0 (fi) 1997-05-07
ES2163528T3 (es) 2002-02-01
IL115879A (en) 2001-08-08
RU2164803C2 (ru) 2001-04-10
NO322048B1 (no) 2006-08-07
CN1090508C (zh) 2002-09-11
CN1162921A (zh) 1997-10-22
CA2203396A1 (fr) 1996-05-17
TR199501391A2 (tr) 1996-06-21
HUT77560A (hu) 1998-06-29
NZ295492A (en) 1998-06-26
EP0789585B1 (fr) 2001-09-12
DK0789585T3 (da) 2001-11-12
BR9509634A (pt) 1998-01-06
MY112593A (en) 2001-07-31
KR970706844A (ko) 1997-12-01
TW407057B (en) 2000-10-01
CZ129497A3 (cs) 1998-02-18
NO972065D0 (no) 1997-05-05
IS4468A (is) 1997-04-21
DE69522702T2 (de) 2002-07-11
ATE205399T1 (de) 2001-09-15
CZ287256B6 (en) 2000-10-11
NO972065L (no) 1997-05-05
PT789585E (pt) 2002-01-30
SE504185C2 (sv) 1996-12-02
EE9700218A (et) 1998-02-16
AU695719B2 (en) 1998-08-20
ZA959377B (en) 1996-05-08
SE9403831L (sv) 1996-05-09
WO1996014084A1 (fr) 1996-05-17
KR100416677B1 (ko) 2004-06-16
IL115879A0 (en) 1996-01-31
SE9403831D0 (sv) 1994-11-08
MX9703339A (es) 1997-07-31
AU3884695A (en) 1996-05-31
JPH10508598A (ja) 1998-08-25
DE69522702D1 (de) 2001-10-18

Similar Documents

Publication Publication Date Title
US10406226B2 (en) Method of manufacturing VEGF antagonist fusion proteins
RU2043118C1 (ru) Способ получения инъекционной формы эритропоэтина
US7803762B1 (en) Ready-to-use bivalirudin compositions
CZ281598B6 (cs) Farmaceutické prostředky s obsahem ranitidinu
SK47298A3 (en) Stable pharmaceutical forms of administration containing parathormone
SK53597A3 (en) A storage stable water solution for infusion containing a thrombin inhibitor
EA039003B1 (ru) Фармацевтическая композиция для парентерального введения, содержащая карглумовую кислоту
EP0298192B1 (fr) Solutions stables et injectables de sels de vincristine
BRPI0214412B1 (pt) solução aquosa contendo ácido glicônico, manitol e tween 80 para injeção de antagonista de hormônio liberador de gonadotrofina (lhrh), bem como seu processo de preparação
CZ252897A3 (cs) Farmaceutický prostředek
BG63621B1 (bg) Стабилизирани фармацевтични състави на база хинупристин и далфопристин и тяхното получаване
NZ231094A (en) Pharmaceutical composition containing 1-diphenylmethyl-4-((2-(4-methylphenyl)-5-methyl-1h-imidazol-4-yl)methyl)-piperazine